Literature DB >> 7801600

Identification and removal of polymer- and aggregate-forming proteins in human plasma albumin preparations.

L B Jensen1, J Dam, B Teisner.   

Abstract

The presence of the glycoproteins haptoglobin and hemopexin in human plasma albumin (HPA) solutions were demonstrated to be responsible for the formation of polymers and aggregates during heat treatment for 10 h at 60 degrees C. Apart from haptoglobin and hemopexin three other contaminating proteins were identified as transferrin, Gc-globulin and beta 2-glycoprotein. During heat treatment the antigenicity of haptoglobin and hemopexin changed markedly and more than 90% of the antigens appeared as aggregates in the void volume during the following size chromatography. Without loss of albumin haptoglobin and hemopexin were removed from the HPA preparation by lectin (concanavalin A) affinity chromatography. The haptoglobin- and hemopexin-depleted HPA preparation did not form aggregates or polymers during heat treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7801600     DOI: 10.1111/j.1423-0410.1994.tb01646.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

1.  Stability of human serum albumin during bioprocessing: denaturation and aggregation during processing of albumin paste.

Authors:  J J Lin; J D Meyer; J F Carpenter; M C Manning
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

Review 2.  An alternative view of the proposed alternative activities of hemopexin.

Authors:  Marcia R Mauk; Ann Smith; A Grant Mauk
Journal:  Protein Sci       Date:  2011-03-30       Impact factor: 6.725

3.  Optimizing extracellular vesicles' isolation from chronic lymphocytic leukemia patient plasma and cell line supernatant.

Authors:  Sara Elgamal; Emanuele Cocucci; Ellen J Sass; Xiaokui M Mo; Angela R Blissett; Edward P Calomeni; Kerry A Rogers; Jennifer A Woyach; Seema A Bhat; Natarajan Muthusamy; Amy J Johnson; Karilyn T Larkin; John C Byrd
Journal:  JCI Insight       Date:  2021-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.